130 related articles for article (PubMed ID: 24264142)
1. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.
Li D; Sun X; Zhang L; Yan B; Xie S; Liu R; Liu M; Zhou J
Protein Cell; 2013 Nov; ():. PubMed ID: 24264142
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.
Li D; Sun X; Zhang L; Yan B; Xie S; Liu R; Liu M; Zhou J
Protein Cell; 2014 Mar; 5(3):214-23. PubMed ID: 24474193
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer.
Yang Y; Sun Y; Wang H; Li H; Zhang M; Zhou L; Meng X; Wu Y; Liu P; Liu X; Zhang J; Tan X
Oncol Lett; 2018 Dec; 16(6):7295-7301. PubMed ID: 30546469
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6.
Wu X; Zhang X; Liu P; Wang Y
Pancreatology; 2023 Sep; 23(6):630-641. PubMed ID: 37460341
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
6. Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer.
Vuletić A; Mirjačić Martinović K; Spasić J
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258065
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migration.
Williams KA; Zhang M; Xiang S; Hu C; Wu JY; Zhang S; Ryan M; Cox AD; Der CJ; Fang B; Koomen J; Haura E; Bepler G; Nicosia SV; Matthias P; Wang C; Bai W; Zhang X
J Biol Chem; 2013 Nov; 288(46):33156-70. PubMed ID: 24089523
[TBL] [Abstract][Full Text] [Related]
8. Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.
Salian-Mehta S; Xu M; McKinsey TA; Tobet S; Wierman ME
J Biol Chem; 2015 May; 290(22):14045-56. PubMed ID: 25873389
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase 6 in health and disease.
Seidel C; Schnekenburger M; Dicato M; Diederich M
Epigenomics; 2015; 7(1):103-18. PubMed ID: 25687470
[TBL] [Abstract][Full Text] [Related]
10. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
11. Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer.
Wang G; He J; Zhao J; Yun W; Xie C; Taub JW; Azmi A; Mohammad RM; Dong Y; Kong W; Guo Y; Ge Y
PLoS One; 2012; 7(12):e52095. PubMed ID: 23251689
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
[TBL] [Abstract][Full Text] [Related]
13. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.
Tao H; Chen YY; Sun ZW; Chen HL; Chen M
J Cell Biochem; 2018 Aug; 119(8):6623-6632. PubMed ID: 29665050
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis.
Gao YS; Hubbert CC; Lu J; Lee YS; Lee JY; Yao TP
Mol Cell Biol; 2007 Dec; 27(24):8637-47. PubMed ID: 17938201
[TBL] [Abstract][Full Text] [Related]
15. The role of HDAC6 in cancer.
Aldana-Masangkay GI; Sakamoto KM
J Biomed Biotechnol; 2011; 2011():875824. PubMed ID: 21076528
[TBL] [Abstract][Full Text] [Related]
16. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation.
Tsuji G; Okiyama N; Villarroel VA; Katz SI
J Allergy Clin Immunol; 2015 May; 135(5):1228-39. PubMed ID: 25458911
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease.
Batchu SN; Brijmohan AS; Advani A
Clin Sci (Lond); 2016 Jun; 130(12):987-1003. PubMed ID: 27154743
[TBL] [Abstract][Full Text] [Related]
19. Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6.
Leucker TM; Nomura Y; Kim JH; Bhatta A; Wang V; Wecker A; Jandu S; Santhanam L; Berkowitz D; Romer L; Pandey D
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H711-H720. PubMed ID: 28188215
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes.
Li Y; Shin D; Kwon SH
FEBS J; 2013 Feb; 280(3):775-93. PubMed ID: 23181831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
